What can we help you find?

Leading the way in transplantation

Filter results for:

Publishing scientific papers and recommendations is a core activity for the ESOT community.

  • It is not only extending donor criteria: it is extending the donor pool. A cross-sectional survey from the European Society of Organ Transplantation
    First published: 02 February 2021 Transplant International PubMed
  • Consensus statement on normothermic regional perfusion in donation after circulatory death: report from the European Society for Organ Transplantation’s Transplantation Learning Journey

    First published: 18 June 2021 Transplant InternationalPubMed
  • Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): overview of the available evidence and guidance for shared decision making

    First published: 19 June 2021 Transplant International  – PubMed
  • Organ transplants of the future: planning for innovations including xenotransplantation
    First published: 28 August 2021 Transplant InternationalPubMed
  • Building a bridge between patients and transplant healthcare professionals – A descriptive study

    First published: 15 September 2021 Transplant InternationalPubMed
  • A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation

    First published: 27 September 2021 Transplant International PubMed

  • Clinical trial design and endpoints in kidney transplantation
    Transplant International

    Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
    Allison Tong , Rainer Oberbauer , Maria Irene Bellini , Klemens Budde , Fergus J. Caskey, Fabienne Dobbels , Liset Pengel , Lionel Rostaing , Stefan Schneeberger and Maarten Naesens
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10135

    Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
    Daniel Seron , Marion Rabant, Jan Ulrich Becker , Candice Roufosse , Maria Irene Bellini , Georg A. Böhmig , Klemens Budde , Fritz Diekmann, Denis Glotz, Luuk Hilbrands , Alexandre Loupy, Rainer Oberbauer , Liset Pengel , Stefan Schneeberger and Maarten NaesensPublished on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10135

    Surrogate Endpoints for Late Kidney Transplantation Failure
    Maarten Naesens , Klemens Budde , Luuk Hilbrands , Rainer Oberbauer , Maria Irene Bellini , Denis Glotz, Josep Grinyó , Uwe Heemann , Ina Jochmans , Liset Pengel , Marlies Reinders, Stefan Schneeberger and Alexandre Loupy
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10136

    Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
    Maarten Naesens , Alexandre Loupy, Luuk Hilbrands , Rainer Oberbauer , Maria Irene Bellini , Denis Glotz, Josep Grinyó , Uwe Heemann , Ina Jochmans , Liset Pengel , Marlies Reinders, Stefan Schneeberger and Klemens Budde
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10137

    Alloimmune Risk Stratification for Kidney Transplant Rejection
    Oriol Bestard, Olivier Thaunat , Maria Irene Bellini , Georg A. Böhmig , Klemens Budde , Frans Claas , Lionel Couzi , Lucrezia Furian , Uwe Heemann , Nizam Mamode, Rainer Oberbauer , Liset Pengel , Stefan Schneeberger and Maarten Naesens
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10138

    Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
    Luuk Hilbrands , Klemens Budde , Maria Irene Bellini , Fritz Diekmann, Lucrezia Furian , Josep Grinyó , Uwe Heemann, Dennis A. Hesselink , Alexandre Loupy, Rainer Oberbauer , Liset Pengel , Marlies Reinders, Stefan Schneeberger and Maarten Naesens
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10139

    Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
    Candice Roufosse , Jan Ulrich Becker , Marion Rabant, Daniel Seron , Maria Irene Bellini , Georg A. Böhmig , Klemens Budde , Fritz Diekmann, Denis Glotz, Luuk Hilbrands , Alexandre Loupy, Rainer Oberbauer , Liset Pengel , Stefan Schneeberger and Maarten Naesens
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10140

    Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
    Jan Ulrich Becker , Daniel Seron , Marion Rabant, Candice Roufosse and Maarten Naesens
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2022.10141

    Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
    Maarten Naesens , Stefan Schneeberger , the ESOT Working Group , Maarten Naesens, Jan Ulrich Becker, Maria Irene Bellini, Oriol Bestard, Georg A. Böhmig, Klemens Budde, Fergus Caskey, Frans Claas, Lionel Couzi, Fritz Diekmann, Fabienne Dobbels, Lucrezia Furian, Denis Glotz, Josep Grinyó, Uwe Heemann, Dennis Hesselink, Luuk Hilbrands, Ina Jochmans, Alexandre Loupy, Nizam Mamode, Rainer Oberbauer, Liset Pengel, Marion Rabant, Marlies Reinders, Lionel Rostaing, Candice Roufosse, Stefan Schneeberger, Daniel Seron, Olivier Thaunat and Allison Tong
    Published on 20 May 2022
    Transpl Int doi: 10.3389/ti.2021.10142

 

Join our community today!

Learn more